Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index; 79 of the 136 sources its claims cite were checked for support.

Connecting metabolome and phenotype: recent advances in functional metabolomics tools for the identification of bioactive natural products

Open access

Abstract

Covering: 1995 to 2023Advances in bioanalytical methods, particularly mass spectrometry, have provided valuable molecular insights into the mechanisms of life. Non-targeted metabolomics aims to detect and (relatively) quantify all observable small molecules present in a biological system. By comparing small molecule abundances between different conditions or timepoints in a biological system, researchers can generate new hypotheses and begin to understand causes of observed phenotypes. Functional metabolomics aims to investigate the functional roles of metabolites at the scale of the metabolome. However, most functional metabolomics studies rely on indirect measurements and correlation analyses, which leads to ambiguity in the precise definition of functional metabolomics. In contrast, the field of natural products has a history of identifying the structures and bioactivities of primary and specialized metabolites. Here, we propose to expand and reframe functional metabolomics by integrating concepts from the fields of natural products and chemical biology. We highlight emerging functional metabolomics approaches that shift the focus from correlation to physical interactions, and we discuss how this allows researchers to uncover causal relationships between molecules and phenotypes.

Overview

CoChat Summary

## TL;DR

This perspective argues that functional metabolomics should move beyond correlation-based associations toward workflows that directly capture physical interactions and chemical reactions between metabolites and biological targets. It surveys experimental and computational tools—especially those adapted from natural products research—to connect molecules to phenotypes and prioritize bioactive compounds.

## Key findings

  • The paper frames most current functional metabolomics as indirect: many workflows infer function from gene deletions, knockdowns, or enrichment analyses rather than measuring metabolite function directly.
  • It highlights a range of tools that shift toward causality, including affinity-selection MS, native metabolomics, NMR-based approaches, stable-isotope labeling/flux analysis, and bioactivity-based metabolomics.
  • In correlation-based studies, the authors cite a functional metabolomics pipeline that revealed functions of 4913 genes in *Saccharomyces cerevisiae* and another CRISPRi study of 30 E. coli strains that showed localized metabolic buffering of enzyme perturbations.
  • For computational deconvolution, the paper notes that public MS/MS spectral libraries in MassBank, MassBank of North America, and GNPS contain 587,213 experimental MS/MS reference spectra in aggregate.

## Methods

  • Perspective/review article covering literature from 1995 to 2023, synthesizing advances in functional metabolomics and natural products discovery.
  • The paper organizes methods into experimental and computational categories, including correlation/guilt-by-association, bioactivity-based metabolomics, metabolic flux analysis and stable isotope labeling, affinity-based metabolomics, native metabolomics, chemical metabolomics, and machine-learning-based structure/activity prediction.
  • It does not report a new original dataset; instead, it reviews prior studies and compares how different workflows infer metabolite function and bioactivity.

## Limitations

  • The paper states that many functional metabolomics studies rely on indirect measurements and correlation analyses, which creates ambiguity in the definition of “functional metabolomics.”
  • It also notes that a major bottleneck remains the limited compound identification rate due to restricted spectral-library coverage, incomplete understanding of MS/MS fragmentation, and sometimes insufficient CID fragmentation.
  • Evident from the text: because this is a perspective/review, it does not present a single unified experimental protocol or new empirical validation of the proposed framework.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1039/d3np00050h

Cites

173 of 173 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Metabolomics strategies aim to provide biological insights at the molecular level. Non-targeted metabolomics (left side) aims to provide inventories of (ideally) all metabolites in a given sample and compare them between different biological stages. Functional metabolomics approaches (right side) aim to add functional associations (e.g., genes) or direct causative relations between particular metabolites and biological functions (e.g., bioactivity or enzyme inhibition).
Fig. 1 Metabolomics strategies aim to provide biological insights at the molecular level. Non-targeted metabolomics (left side) aims to provide inventories of (ideally) all metabolites in a given sample and compare them between different biological stages. Functional metabolomics approaches (right side) aim to add functional associations (e.g., genes) or direct causative relations between particular metabolites and biological functions (e.g., bioactivity or enzyme inhibition).CC BY · PubMed Central
Fig. 2 Metabolomics and functional metabolomics concept. Panels A–D highlight “classic” non-targeted metabolomics and functional metabolomics approaches. While “classic” non-targeted metabolomics approaches (Panel A) typically assess a molecular driver between different biological conditions (e.g., sick vs. healthy), functional metabolomics approaches (Panel B) make use of systematic perturbations (e.g., genome-wide knockout studies) to associate metabolites to specific genes. In addition to purely association-based insights, molecular causative functional metabolomics approaches (Panel C and D) aim to measure direct biological or biophysical properties (e.g., antimicrobial activity or protein binding).
Fig. 2 Metabolomics and functional metabolomics concept. Panels A–D highlight “classic” non-targeted metabolomics and functional metabolomics approaches. While “classic” non-targeted metabolomics approaches (Panel A) typically assess a molecular driver between different biological conditions (e.g., sick vs. healthy), functional metabolomics approaches (Panel B) make use of systematic perturbations (e.g., genome-wide knockout studies) to associate metabolites to specific genes. In addition to purely association-based insights, molecular causative functional metabolomics approaches (Panel C and D) aim to measure direct biological or biophysical properties (e.g., antimicrobial activity or protein binding).CC BY · PubMed Central
Fig. 3 Bioactivity-guided and functional metabolomics approaches in natural products discovery. Classic NPs bioactivity-driven pipeline (Panel A), high-throughput phenotyping (Panel B), enzyme affinity screening approach (Panel C), chemical metabolomics approach (Panel D).
Fig. 3 Bioactivity-guided and functional metabolomics approaches in natural products discovery. Classic NPs bioactivity-driven pipeline (Panel A), high-throughput phenotyping (Panel B), enzyme affinity screening approach (Panel C), chemical metabolomics approach (Panel D).CC BY · PubMed Central
Fig. 4 Native MS approach and discovery. (Panel A) A schematic overview of the native metabolomics workflow. This native metabolomics workflow utilizes a microflow UHPLC coupled to a mass spectrometer in addition to a make-up HPLC pump for post-column pH modulation alongside direct infusion of a target protein or metal. (Panel B) Molecular interaction between a small molecule metabolite and directly infused metal salt is revealed using ion identity molecular networking (IIMN). (Panel C) This strategy facilitated the discovery of yersiniabactin–zinc binding along with zinc-binding by the yersiniabactin-truncation HPTT-COOH. (Panel D) Other modification of the method used proteases as binding partner to identify small molecule–protein interactions, which resulted in (Panel E) the discovery of novel chymotrypsin inhibitors. Modified from Reher et al.83
Fig. 4 Native MS approach and discovery. (Panel A) A schematic overview of the native metabolomics workflow. This native metabolomics workflow utilizes a microflow UHPLC coupled to a mass spectrometer in addition to a make-up HPLC pump for post-column pH modulation alongside direct infusion of a target protein or metal. (Panel B) Molecular interaction between a small molecule metabolite and directly infused metal salt is revealed using ion identity molecular networking (IIMN). (Panel C) This strategy facilitated the discovery of yersiniabactin–zinc binding along with zinc-binding by the yersiniabactin-truncation HPTT-COOH. (Panel D) Other modification of the method used proteases as binding partner to identify small molecule–protein interactions, which resulted in (Panel E) the discovery of novel chymotrypsin inhibitors. Modified from Reher et al.83CC BY · PubMed Central
Fig. 5 Computational bioactivity prediction. From untargeted metabolomics experiments, two computational strategies try to ascribe bioactivity. First (top) is the direct prediction of activity from tandem mass spectrometry data, and second (bottom) is the computational deconvolution of bioactivity from fractionation experiments. In both approaches, the computational predictions, once validated, should be deposited in a community bioactivity knowledgebase to be used in future analyses and to improve future tools.
Fig. 5 Computational bioactivity prediction. From untargeted metabolomics experiments, two computational strategies try to ascribe bioactivity. First (top) is the direct prediction of activity from tandem mass spectrometry data, and second (bottom) is the computational deconvolution of bioactivity from fractionation experiments. In both approaches, the computational predictions, once validated, should be deposited in a community bioactivity knowledgebase to be used in future analyses and to improve future tools.CC BY · PubMed Central
Giovanni Andrea Vitale
Giovanni Andrea VitaleCC BY · PubMed Central
Christian Geibel
Christian GeibelCC BY · PubMed Central
Vidit Minda
Vidit MindaCC BY · PubMed Central
Mingxun Wang
Mingxun WangCC BY · PubMed Central
Allegra T. Aron
Allegra T. AronCC BY · PubMed Central
Daniel Petras
Daniel PetrasCC BY · PubMed Central

Verification

Claims the paper makes

57 Valid · 4 Not valid · 23 Not checked · 13 Own results and interpretations

50 more claims · 31 with their cited sources checked

Create a free account to see all 97 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 28
  • The quote only partly states this claim. 1
  • Probably not a substantial claim. 19

Create a free account to see these claims.

Citations

Cites

Show all 172 references

Research works printed but not linked: 3

  1. World Health Organization , WHO global report on traditional and complementary medicine 2019 , World Health Organization , Geneva , 2019
  2. Genilloud, 2019, Antimicrobials, 51, 81
  3. Huang, 2015, Proc. Natl. Acad. Sci. U. S. A., 112, E1974

Cited by

See all 66

Metadata

Authors
Vitale, G. A., Geibel, C., Minda, V., Wang, M., Aron, A. T., & Petras, D.
Affiliations
  • University of Tübingen (DE)
  • University of Denver (US)
  • University of California, Riverside (US)
Corresponding author
  • Wang, Mingxun
  • Aron, Allegra T.
  • Petras, Daniel
Venue
Natural Product Reports
Published
2024
Volume
41
Issue
6
Pages
885-904
ISSN
  • 0265-0568 (ISSN-L)
  • 1460-4752
OpenAlex
W4391816699
Cited by
66
References
172
Citations by year
2026: 32 · 2025: 26 · 2024: 8
FWCI
2.69
Type
journal article
Language
en
Open access
Locations
  • Natural Product Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
Funders
  • Deutsche Forschungsgemeinschaft (CMFI Cluster of Excellence (EXC 2124), Collaborative Research Center CellMap (TRR 261))
  • University of California, Riverside
  • National Institutes of Health (5U24DK133658-02)
  • Joint Genome Institute
  • U.S. Department of Energy (DE-AC02-05CH11231)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
Keywords
natural products, untargeted metabolomics, small molecule interactions, chemical biology, bioactive natural products
MeSH terms
Biological Products, Phenotype, Mass Spectrometry, Molecular Structure, Metabolomics, Metabolome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Connecting metabolome and phenotype: recent advances in functional metabolomics tools for the identification of bioactive natural products. https://app.cochat.ai/papers/10.1039/d3np00050h
The paper
Vitale, G. A., Geibel, C., Minda, V., Wang, M., Aron, A. T., & Petras, D. (2024). Connecting metabolome and phenotype: recent advances in functional metabolomics tools for the identification of bioactive natural products. Natural Product Reports. https://doi.org/10.1039/d3np00050h

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.